Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Discovery of 2-(3,4-dichlorophenoxy)-N-(2-morpholin-4-ylethyl)acetamide: A selective σ1 receptor ligand with antinociceptive effect.
Navarrete-Vázquez G, Austrich-Olivares A, Godínez-Chaparro B, Hidalgo-Figueroa S, Estrada-Soto S, Hernández-Núñez E, Torres-Gómez H, Schepmann D, Wünsch B. Navarrete-Vázquez G, et al. Biomed Pharmacother. 2016 Apr;79:284-93. doi: 10.1016/j.biopha.2016.02.038. Epub 2016 Mar 14. Biomed Pharmacother. 2016. PMID: 27044839
Endocannabinoid System Components as Potential Biomarkers in Psychiatry.
Navarrete F, García-Gutiérrez MS, Jurado-Barba R, Rubio G, Gasparyan A, Austrich-Olivares A, Manzanares J. Navarrete F, et al. Front Psychiatry. 2020 Apr 27;11:315. doi: 10.3389/fpsyt.2020.00315. eCollection 2020. Front Psychiatry. 2020. PMID: 32395111 Free PMC article. Review.
Synergistic Interaction of a Gabapentin- Mangiferin Combination in Formalin-Induced Secondary Mechanical Allodynia and Hyperalgesia in Rats Is Mediated by Activation of NO-Cyclic GMP-ATP-Sensitive K+ Channel Pathway.
Godínez-Chaparro B, Quiñonez-Bastidas GN, Rojas-Hernández IR, Austrich-Olivares AM, Mata-Bermudez A. Godínez-Chaparro B, et al. Among authors: austrich olivares am. Drug Dev Res. 2017 Dec;78(8):390-402. doi: 10.1002/ddr.21411. Epub 2017 Sep 20. Drug Dev Res. 2017. PMID: 28940250